VP, Head Of Global BD Cardiovascular & Metabolism, Endocrinology And Fertility at Healthcare Business of Merck
Frankfurt, Hesse, Germany
Join Prog.AI to see contacts
Join Prog.AI to see contacts
Summary
🤩
Rockstar
Jan Moeller is a veteran business development and M&A leader with over 18 years of experience driving strategic growth in pharmaceuticals, biotech, specialty chemicals, and life sciences. As VP and Head of Global BD for Cardiovascular, Metabolism, Endocrinology, and Fertility at Merck, he leads cross-border dealmaking across major growth markets, executing transactions from licensing deals to multi-billion dollar M&A. He combines corporate finance rigor from early career transaction roles with hands-on commercial BD leadership, delivering complex, cross-functional projects under pressure. Known for a solution-focused mindset and sector depth, he has a track record of creating value through partnerships, acquisitions, and divestitures. Based in Frankfurt, he uniquely pairs executive dealcraft with a curious technical streak—contributing backend code and documentation to an open-source project for Kerbal Space Program. His career reflects consistent upward leadership progression and a talent for aligning scientific portfolios with commercial strategy.
Contributions:11 commits, 2 PRs, 3 comments in 8 days
Contributions summary:Jan primarily contributed to the back-end functionality of the krpc project. They fixed existing code, added the `ScienceSubject` class and related functionality, and implemented basic waypoint interaction. Additionally, the user made code refactoring and documentation improvements to enhance code clarity.
Contributions:224 commits, 327 pushes, 4 branches in 1 year 4 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Jan Moeller - VP, Head Of Global BD Cardiovascular & Metabolism, Endocrinology And Fertility at Healthcare Business of Merck